相关实验视频

Updated: Jun 15, 2025

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

早期的干扰素兰巴达生成是由iPS衍生的肝细胞样细胞中的双链RNA诱导的

Vasile Mihai Sularea¹, Ruchi Sharma², David C Hay³

¹School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St, Dublin, D02R590, Ireland.

Oxford open immunology

|August 28, 2024

概括

来自诱导的多能干细胞的肝细胞样细胞有效地产生III型干扰素作为对病毒RNA的反应. 这一发现突显了肝细胞中一个关键的先天抗病毒防御机制.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
干细胞生物学干细胞生物学

背景情况:

肝炎病毒导致全球重大健康问题.
肝细胞的先天免疫反应至关重要,但研究不足.
干扰素兰巴达 (IFNL) 是抗病毒防御的关键,但其在肝细胞中的作用尚不清楚.

研究的目的:

通过使用代孕系统调查肝脏干扰素兰巴达 (IFNL) 表达.
探索细胞质模式识别受体 (PRR) 在肝细胞抗病毒反应中的作用.
描述肝细胞样细胞 (HLC) 对病毒RNA的先天免疫反应.

主要方法:

使用诱导多能干细胞 (iPS) 衍生的肝细胞样细胞 (HLC).
用类似病毒的RNA连接体刺激的HLC.
测量了III型干扰素和干扰素刺激基因 (ISG) 的基因表达.
研究了细胞质PRRs的作用,包括蛋白激酶RNA依赖 (PKR) 和RIG-I类受体 (RLR).

主要成果:

在用病毒RNA刺激后,HLCs显示III型干扰素基因表达显著增加,增加了一千倍.
与III型相比,I型干扰素表达的诱导程度较小.
诱导ISG15和CXCL10证实了对干扰素依赖的抗病毒活性的激活.
肝细胞利用像PKR和RLR这样的PRR来检测双链RNA.

结论:

肝细胞样细胞有效地产生一种天生的抗病毒反应,其特征是III型干扰素诱导.
来自iPS的HLC可以作为研究肝脏抗病毒免疫力的有价值模型.
这项研究阐明了肝细胞对病毒感染的先天免疫防御的一个关键方面.

关键词:

肝细胞肝细胞感应RNA的感应RNA.抗病毒反应的抗病毒反应.干扰子干扰子干扰子肝脏肝脏肝脏肝脏肝脏肝脏

更多相关视频

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

相关概念视频

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...